Buy & Sell Expeditors International of Wshngtn Inc (EXPD) – Expeditors International of Wshngtn Inc Price Today
Aura AI Summary
Key Stats
- $21.38BMarket Cap
- IndustrialsSector
- -7.46%3M Drawdown
- $20.62BEnterprise Value
- 0.99%Dividend Yield
- 29% Buy | 71% SellTrading Activity
- 42 daysTypical Hold Time
Expeditors International of Wshngtn Inc (EXPD) is currently valued at a market capitalization of $21.38B, with an enterprise value of $20.62B. Over the past 52 weeks, Expeditors International of Wshngtn Inc has traded between a low of $111.37 and a high of $165.78, highlighting its annual price range. Over the past three months, Expeditors International of Wshngtn Inc has recorded a drawdown of -7.46%, reflecting recent price volatility. Expeditors International of Wshngtn Inc offers a dividend yield of 0.99%, with the most recent dividend of $0.81 paid on 01 Jun 26. On average, investors hold Expeditors International of Wshngtn Inc for approximately 42 days, indicating typical investor behavior on the platform.
About Expeditors International of Wshngtn Inc
Expeditors International of Washington is a non-asset-based third-party logistics provider, mainly focused on international freight forwarding. It employs sophisticated IT systems and contracts with airlines and ocean carriers to move customers' freight across the globe. The firm operates more than 200 full-service office locations worldwide, in addition to numerous satellite locations. In 2021, Expeditors derived 38% of consolidated net revenue from airfreight, 27% from ocean freight, and 35% from customs brokerage and other services.
Most Recent News
Investigation into Wealthfront's securities fraud continues amid sharp stock drops and deposit declines.
Glancy Prongay & Murray LLP is investigating Wealthfront Corporation for potential securities law violations after the company reported significant financial setbacks. Wealthfront's stock fell sharply following disclosures of large net deposit outflo...
ControlUp named Leader for third year in Gartner's 2026 Digital Employee Experience Magic Quadrant.
ControlUp has been recognized as a Leader for the third consecutive year in Gartner's 2026 Magic Quadrant for Digital Employee Experience (DEX) Management Tools. This highlights ControlUp's innovation in Autonomous Endpoint Management using agentic A...
Gilead and Merck halt lung cancer trial but report positive HIV drug Phase 3 results.
Gilead Sciences and Merck have stopped their Phase 3 trial combining Trodelvy and Keytruda for metastatic non-small cell lung cancer after it failed to show statistically significant benefits. However, they announced positive Phase 3 results for a ne...